CompoAtlas

Pure Performance 100% Clean Mass Gainer Vanilla Flavour

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Isolat de protéine de lactosérum

Source : Bos taurus - Lait

Potency : 90 % Whey protein

2.03 gNot calculated
Caséinate de calcium

Source : Bos taurus - Lait

Potency : 88.5 % Protein

229.25 mgNot calculated
Hydrolysat de protéine du lactosérum

Source : Bos taurus - Lait

Potency : 75 % Whey protein

1.15 gNot calculated
Concentré de protéine de lactosérum

Source : Bos taurus - Lait

Potency : 85 % Whey protein

3.1 gNot calculated
Protéine de pois

Source : Protéine de pois

Potency : 82 % Protein

3.5 gNot calculated
N-(Aminoiminométhyl)-N-méthylglycine monohydraté

Source : Créatine monohydratée

0.75 gNot calculated
Maltodextrine

Source : Maltodextrin

33.625 gNot calculated
Linum usitatissimum

Source : Graine(s)

2.75 mgNot calculated
Extrait de fève de café vert

Source : Coffea canephora - Graine

Extract : Matériel brut sec

Extraction ratio : 10:1

Dry plant equivalent : 552.5 mg

Potency : 45 % Chlorogenic acids

55.25 mgNot calculated
Medicago sativa

Source : Sommité

0.475 mgNot calculated
Bifidobacterium animalis subsp. lactis

Source : BL-04

0.1375 mgNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

0.1375 mgNot calculated
Lactobacillus acidophilus

Source : LA-14

0.35 mgNot calculated
Lactobacillus acidophilus

Source : Cellule entière

0.35 mgNot calculated
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Source : Aspergillus niger - En entier

2.75 mgNot calculated
Protéase fongique

Source : Aspergillus niger - En entier

2.75 mgNot calculated
4-alpha-D-glucane glucanohydrolase

Source : Alpha-amylase

0.55 mgNot calculated
4-alpha-D-glucane glucanohydrolase

Source : Aspergillus niger - En entier

0.55 mgNot calculated
Triacylglycérol lipase

Source : Aspergillus niger - En entier

0.0175 mgNot calculated
Papaïne

Source : Carica papaya - fruit

25.75 mgNot calculated
Isolat de protéine de lait

Source : Bos taurus - Lait

Potency : 80 % Protein

0.925 gNot calculated
Isolat de protéine de boeuf

Source : Bos taurus - Muscle

Potency : 95 % Protein

0.925 gNot calculated
Micelles de caséine

Source : Micellar casein

Potency : 81 % Protein

229.25 mgNot calculated
Micelles de caséine

Source : Bos taurus - Lait

Potency : 81 % Protein

229.25 mgNot calculated
Colostrum bovin

Source : Bos taurus - colostrum

18.25 mgNot calculated
Caséine, sel de sodium

Source : Bos taurus - Lait

Potency : 85 % Protein

18.25 mgNot calculated
Caséine, sel de sodium

Source : Sodium caseinate

Potency : 85 % Protein

18.25 mgNot calculated
Astragalus membranaceus

Source : Racine

6.25 mgNot calculated
Panax notoginseng

Source : Racine

6.25 mgNot calculated
4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase

Source : Aspergillus niger - En entier

13.75 FCC CUNot calculated
Lactobacillus acidophilus

Source : LA-14

0.07 Milliards d'UFCNot calculated
Lactobacillus acidophilus

Source : Cellule entière

0.07 Milliards d'UFCNot calculated
Triacylglycérol lipase

Source : Aspergillus niger - En entier

1.375 FCC LUNot calculated
Bifidobacterium animalis subsp. lactis

Source : BL-04

0.07 Milliards d'UFCNot calculated
Bifidobacterium animalis subsp. lactis

Source : Cellule entière

0.07 Milliards d'UFCNot calculated
Protéase fongique

Source : Aspergillus niger - En entier

138 Unités d'hémoglobine basées sur la tyrosine, du FCCNot calculated
4-alpha-D-glucane glucanohydrolase

Source : Alpha-amylase

41.5 Unités d'alpha-amylase dextrinifiante du FCCNot calculated
4-alpha-D-glucane glucanohydrolase

Source : Aspergillus niger - En entier

41.5 Unités d'alpha-amylase dextrinifiante du FCCNot calculated
Papaïne

Source : Carica papaya - fruit

2,530.75 Unités de papaïne du FCCNot calculated

Non-medicinal ingredients

Poudre de germe d'amaranthe, Gomme de Guar, Poudre de germe de sarrasin, Sucralose, Dioxyde de silicium, Gomme de xanthane, Mélange de germes, Acacia, Feuille de Stevia rebaudiana, Saveur de vanille, Poudre de germe de quinoa, Maltodextrine, Millet, Chlorure de sodium, Son d'Avena sativa (Avoine), Extrait de fruit de monk, Albumen

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Mesures4 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Increases muscle size when used in conjunction with a resistance training regimen. Improves strength and power in repetitive bouts of brief, highly-intense physical activity. Source of calories which contributes to weight gain. Source of carbohydrates to support energy production. Helps to [maintain performance/promote endurance] in extended (greater than 60 min), high intensity exercise. Source of (all) essential amino acids (i.e. histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine) for the maintenance of good health. Source of branched chain amino acids for the maintenance of good health. Source of (essential) amino acids involved in muscle protein synthesis. (Excellent) Source of protein for the maintenance of good health. (Excellent) Source of protein which helps build and repair body tissues. (Excellent) Source of protein which helps build antibodies. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Source of digestive enzymes. Source of enzymes that help digest proteins.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Product record

Licence holder
Wellnx Life Sciences Inc./ Altrex Nutrition/ Wellnx Distribution Inc.
NPN or DIN-HM
80087098
Status
Active licence
Licence date
16 July 2018
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80087098

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Linum usitatissimum
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    Sources cited by Health Canada (1)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    Sources cited by Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Sources cited by Health Canada (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    Sources cited by Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    Sources cited by Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
    • Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    Sources cited by Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.

    Health Canada monograph dated 26 July 2024

  • Medicago sativa
    Read the warning, when it applies and the studies cited

    ALFALFA - MEDICAGO SATIVA

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.

    Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).

    Sources cited by Health Canada (3)
    • Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 29 November 2024

  • Astragalus membranaceus
    Read the warning, when it applies and the studies cited

    ASTRAGALUS - ASTRAGALUS MEMBRANACEUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have an autoimmune disorder (Brinker 2010; Upton 1999).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Astragalus Root. Santa Cruz (CA): American Herbal Pharmacopoeia; 1999.

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use if you have exterior excess, stagnation, yin deficiency or excess heat (Bensky et al. 2004; Chen and Chen 2004).

    Sources cited by Health Canada (2)
    • Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
    • Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.

    Health Canada monograph dated 30 May 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Pure Performance 100% Clean Mass Gainer Vanilla Flavour”, https://compoatlas.com/en/supplements/canada/80087098-pure-performance-100-clean-mass-gainer-vanilla-flavour, updated 16 July 2018.

Enter to analyse, Shift+Enter for a new line